A detailed history of Jump Financial, LLC transactions in Argenx Se stock. As of the latest transaction made, Jump Financial, LLC holds 1,063 shares of ARGX stock, worth $678,544. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,063
Previous 10,118 89.49%
Holding current value
$678,544
Previous $4.35 Million 86.76%
% of portfolio
0.01%
Previous 0.09%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$434.22 - $551.9 $3.93 Million - $5 Million
-9,055 Reduced 89.49%
1,063 $576,000
Q2 2024

Aug 14, 2024

BUY
$356.01 - $451.55 $2.88 Million - $3.65 Million
8,081 Added 396.71%
10,118 $4.35 Million
Q1 2024

May 13, 2024

BUY
$356.95 - $413.29 $727,107 - $841,871
2,037 New
2,037 $802,000
Q3 2023

Oct 21, 2024

SELL
$369.35 - $548.43 $4.8 Million - $7.13 Million
-13,000 Reduced 91.55%
1,200 $589,000
Q3 2023

Nov 07, 2023

BUY
$369.35 - $548.43 $443,220 - $658,115
1,200 New
1,200 $589,000
Q1 2023

Oct 21, 2024

BUY
$334.23 - $403.65 $1.36 Million - $1.65 Million
4,082 Added 40.34%
14,200 $5.29 Million
Q1 2023

May 03, 2023

BUY
$334.23 - $403.65 $2.85 Million - $3.44 Million
8,516 Added 149.82%
14,200 $5.29 Million
Q4 2022

Feb 13, 2023

BUY
$342.17 - $402.31 $1.5 Million - $1.76 Million
4,375 Added 334.22%
5,684 $2.15 Million
Q3 2022

Nov 07, 2022

SELL
$343.2 - $395.75 $4.18 Million - $4.82 Million
-12,191 Reduced 90.3%
1,309 $462,000
Q2 2022

Aug 09, 2022

BUY
$269.58 - $378.88 $3.64 Million - $5.11 Million
13,500 New
13,500 $5.12 Million
Q1 2022

May 12, 2022

SELL
$254.45 - $351.06 $203,560 - $280,848
-800 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$272.01 - $353.03 $217,608 - $282,424
800 New
800 $280,000
Q4 2020

Feb 12, 2021

SELL
$248.13 - $308.36 $918,081 - $1.14 Million
-3,700 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$215.51 - $272.51 $797,387 - $1.01 Million
3,700 New
3,700 $971,000

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $35.3B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.